Compared to subtype 1 and the normal subgroup, the expressions of MAPT, ADAM10, BACE1, and PSEN2 in subtype 2 resided in an intermediate state, which implied that subtype 2 might be a transition state from normal to AD. The gene discussed is MAPT; the disease is Alzheimer disease.